SABRE CORP (SABR)

US78573M1045 - Common Stock

3.67  +0.07 (+1.94%)

Premarket: 3.65 -0.02 (-0.54%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SABR. SABR was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. SABR may be in some trouble as it scores bad on both profitability and health. SABR does not seem to be growing, but still is valued expensively.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

SABR had negative earnings in the past year.
In the past year SABR had a positive cash flow from operations.
In the past 5 years SABR reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: SABR reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -6.40%, SABR is not doing good in the industry: 82.09% of the companies in the same industry are doing better.
SABR has a Return On Invested Capital (6.30%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.4%
ROE N/A
ROIC 6.3%
ROA(3y)-12.92%
ROA(5y)-11.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Operating Margin value of 9.35%, SABR perfoms like the industry average, outperforming 52.99% of the companies in the same industry.
SABR's Operating Margin has declined in the last couple of years.
SABR's Gross Margin of 58.80% is fine compared to the rest of the industry. SABR outperforms 69.40% of its industry peers.
SABR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.35%
PM (TTM) N/A
GM 58.8%
OM growth 3YN/A
OM growth 5Y-31.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.61%
GM growth 5Y14.66%

More info and screens

2

2. Health

2.1 Basic Checks

SABR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SABR has more shares outstanding
SABR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SABR is higher compared to a year ago.

2.2 Solvency

SABR has an Altman-Z score of -0.29. This is a bad value and indicates that SABR is not financially healthy and even has some risk of bankruptcy.
SABR's Altman-Z score of -0.29 is on the low side compared to the rest of the industry. SABR is outperformed by 85.82% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.29
ROIC/WACC0.73
WACC8.68%

2.3 Liquidity

SABR has a Current Ratio of 1.02. This is a normal value and indicates that SABR is financially healthy and should not expect problems in meeting its short term obligations.
SABR has a Current ratio of 1.02. This is comparable to the rest of the industry: SABR outperforms 56.72% of its industry peers.
SABR has a Quick Ratio of 1.02. This is a normal value and indicates that SABR is financially healthy and should not expect problems in meeting its short term obligations.
SABR has a Quick ratio of 1.02. This is in the better half of the industry: SABR outperforms 60.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.89% over the past year.
SABR shows a small growth in Revenue. In the last year, the Revenue has grown by 5.26%.
Measured over the past years, SABR shows a decrease in Revenue. The Revenue has been decreasing by -5.54% on average per year.
EPS 1Y (TTM)70.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)5.26%
Revenue growth 3Y29.65%
Revenue growth 5Y-5.54%
Sales Q2Q%3.28%

3.2 Future

The Earnings Per Share is expected to grow by 23.44% on average over the next years. This is a very strong growth
Based on estimates for the next years, SABR will show a small growth in Revenue. The Revenue will grow by 4.39% on average per year.
EPS Next Y67.28%
EPS Next 2Y52.76%
EPS Next 3Y35.03%
EPS Next 5Y23.44%
Revenue Next Year3.79%
Revenue Next 2Y4.66%
Revenue Next 3Y4.54%
Revenue Next 5Y4.39%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SABR. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 20.76 indicates a rather expensive valuation of SABR.
SABR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SABR is cheaper than 61.19% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SABR to the average of the S&P500 Index (23.82), we can say SABR is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 20.76

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SABR.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.97

4.3 Compensation for Growth

SABR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SABR's earnings are expected to grow with 35.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.76%
EPS Next 3Y35.03%

More info and screens

0

5. Dividend

5.1 Amount

SABR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SABRE CORP

NASDAQ:SABR (11/21/2024, 8:00:02 PM)

Premarket: 3.65 -0.02 (-0.54%)

3.67

+0.07 (+1.94%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.42B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.76
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.4%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 9.35%
PM (TTM) N/A
GM 58.8%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)70.89%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y67.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.26%
Revenue growth 3Y29.65%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y